目次

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Biodefence Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing R&D investments by the government
3.2.1.2 Favourable government initiatives in emerging economies
3.2.1.3 Technological developments in biotechnology sector in the developed countries
3.2.2 Market Restraining Factors
3.2.2.1 Low R&D funding in underdeveloped regions
3.2.3 Market Opportunities
3.2.3.1 Increasing list of bio-threat agents
3.2.3.2 Development of advanced biotechnology products
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Biodefence Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Biodefence Market Size Estimation and Forecast by Product
4.4 Vaccines
4.4.1 Anthrax
4.4.1.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.1.2 Market Share by Region, 2023 & 2033 (%)
4.4.2 Small Pox
4.4.2.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.2.2 Market Share by Region, 2023 & 2033 (%)
4.4.3 Botulism
4.4.3.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.3.2 Market Share by Region, 2023 & 2033 (%)
4.4.4 Others
4.4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Biothreat detection devices
4.5.1 Assays and reagents
4.5.1.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.1.2 Market Share by Region, 2023 & 2033 (%)
4.5.2 Detectors
4.5.2.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.2.2 Market Share by Region, 2023 & 2033 (%)
4.5.3 Identifiers
4.5.3.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.3.2 Market Share by Region, 2023 & 2033 (%)
4.5.4 Samplers
4.5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.4.2 Market Share by Region, 2023 & 2033 (%)

5 Biodefence Market Analysis by Region
5.1 Key Findings
5.2 Regional Segment: Market Attractiveness Index
5.3 Biodefence Market Size Estimation and Forecast

6 North America Biodefence Market Analysis
6.1 Key Findings
6.2 North America Biodefence Market Attractiveness Index
6.3 North America Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
6.4 North America Biodefence Market Size Estimation and Forecast by Country
6.5 North America Biodefence Market Size Estimation and Forecast by Product
6.6 U.S. Biodefence Market Analysis
6.7 Canada Biodefence Market Analysis

7 Europe Biodefence Market Analysis
7.1 Key Findings
7.2 Europe Biodefence Market Attractiveness Index
7.3 Europe Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
7.4 Europe Biodefence Market Size Estimation and Forecast by Country
7.5 Europe Biodefence Market Size Estimation and Forecast by Product
7.6 Germany Biodefence Market Analysis
7.7 France Biodefence Market Analysis
7.8 UK Biodefence Market Analysis
7.9 Italy Biodefence Market Analysis
7.10 Spain Biodefence Market Analysis
7.11 Russia Biodefence Market Analysis
7.12 Rest of Europe Biodefence Market Analysis

8 Asia Pacific Biodefence Market Analysis
8.1 Key Findings
8.2 Asia Pacific Biodefence Market Attractiveness Index
8.3 Asia Pacific Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
8.4 Asia Pacific Biodefence Market Size Estimation and Forecast by Country
8.5 Asia Pacific Biodefence Market Size Estimation and Forecast by Product
8.6 Japan Biodefence Market Analysis
8.7 China Biodefence Market Analysis
8.8 India Biodefence Market Analysis
8.9 Australia Biodefence Market Analysis
8.10 South Korea Biodefence Market Analysis
8.11 Rest of Asia Pacific Biodefence Market Analysis

9 Latin America Biodefence Market Analysis
9.1 Key Findings
9.2 Latin America Biodefence Market Attractiveness Index
9.3 Latin America Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 Latin America Biodefence Market Size Estimation and Forecast by Country
9.5 Latin America Biodefence Market Size Estimation and Forecast by Product
9.6 Brazil Biodefence Market Analysis
9.7 Mexico Biodefence Market Analysis
9.8 Rest of Latin America Biodefence Market Analysis

10 MEA Biodefence Market Analysis
10.1 Key Findings
10.2 MEA Biodefence Market Attractiveness Index
10.3 MEA Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 MEA Biodefence Market Size Estimation and Forecast by Country
10.5 MEA Biodefence Market Size Estimation and Forecast by Product
10.6 GCC Biodefence Market Analysis
10.7 South Africa Biodefence Market Analysis
10.8 Rest of MEA Biodefence Market Analysis

11 Company Profiles
11.1 Competitive Landscape, 2021
11.1.1 BioFire Defense
11.1.2 Bruker Corporation
11.1.3 Emergent BioSolutions
11.1.4 Smiths detection
11.2 Alexeter Technologies, LLC,
11.2.1 Company Snapshot
11.2.2 Company Overview
11.2.3 Product Benchmarking
11.3 Altimmune
11.3.1 Company Snapshot
11.3.2 Company Overview
11.3.3 Financial Analysis
11.3.3.1 Net Revenue, 2017-2021
11.3.3.2 R&D, 2017-2021
11.3.4 Product Benchmarking
11.4 ANP Technology
11.4.1 Company Snapshot
11.4.2 Company Overview
11.4.3 Product Benchmarking
11.5 Bavarian Nordic
11.5.1 Company Snapshot
11.5.2 Company Overview
11.5.3 Financial Analysis
11.5.3.1 Net Revenue, 2017-2021
11.5.3.2 R&D, 2017-2021
11.5.3.3 Regional Market Shares, 2021
11.5.4 Product Benchmarking
11.5.5 Strategic Outlook
11.6 Biofire Defense (bioMerieux SA)
11.6.1 Company Snapshot
11.6.2 Company Overview
11.6.3 Financial Analysis
11.6.3.1 Net Revenue, 2017-2021
11.6.3.2 R&D, 2017-2021
11.6.3.3 Regional Market Shares, 2021
11.6.4 Product Benchmarking
11.6.5 Strategic Outlook
11.7 Biosearch Technologies
11.7.1 Company Snapshot
11.7.2 Company Overview
11.7.3 Financial Analysis
11.7.3.1 Net Revenue, 2017-2021
11.7.3.2 Regional Market Shares, 2021
11.7.4 Product Benchmarking
11.8 Bruker
11.8.1 Company Snapshot
11.8.2 Company Overview
11.8.3 Financial Analysis
11.8.3.1 Net Revenue, 2017-2021
11.8.3.2 R&D, 2017-2021
11.8.3.3 Regional Market Shares, 2021
11.8.4 Product Benchmarking
11.9 Electronic Sensor Technology Inc.
11.9.1 Company Snapshot
11.9.2 Company Overview
11.9.3 Product Benchmarking
11.10 Elusys Therapeutics
11.10.1 Company Snapshot
11.10.2 Company Overview
11.10.3 Product Benchmarking
11.10.4 Strategic Outlook
11.11 Emergent BioSolutions Inc.
11.11.1 Company Snapshot
11.11.2 Company Overview
11.11.3 Financial Analysis
11.11.3.1 Net Revenue, 2017-2021
11.11.3.2 R&D, 2017-2021
11.11.4 Product Benchmarking
11.11.5 Strategic Outlook
11.12 Ichor Medical
11.12.1 Company Snapshot
11.12.2 Company Overview
11.12.3 Product Benchmarking
11.13 NanoLogix
11.13.1 Company Snapshot
11.13.2 Company Overview
11.13.3 Product Benchmarking
11.14 New Horizons Diagnostic Corporation
11.14.1 Company Snapshot
11.14.2 Company Overview
11.14.3 Product Benchmarking
11.14.4 Strategic Outlook
11.15 PositiveID Corporation
11.15.1 Company Snapshot
11.15.2 Company Overview
11.15.3 Product Benchmarking
11.16 SIGA Technologies, Inc
11.16.1 Company Snapshot
11.16.2 Company Overview
11.16.3 Financial Analysis
11.16.3.1 Net Revenue, 2017-2021
11.16.3.2 R&D, 2017-2021
11.16.4 Product Benchmarking
11.16.5 Strategic Outlook
11.17 Alnylam Pharmaceuticals
11.17.1 Company Snapshot
11.17.2 Company Overview
11.17.3 Financial Analysis
11.17.3.1 Net Revenue, 2017-2021
11.17.3.2 R&D, 2017-2021
11.17.4 Product Benchmarking
11.17.5 Strategic Outlook
11.18 BBI Detection
11.18.1 Company Snapshot
11.18.2 Company Overview
11.18.3 Product Benchmarking
11.19 Statera Biopharma
11.19.1 Company Snapshot
11.19.2 Company Overview
11.19.3 Financial Analysis
11.19.3.1 Net Revenue, 2017-2021
11.19.3.2 R&D, 2017-2021
11.19.4 Product Benchmarking
11.20 Dynport Vaccine Company
11.20.1 Company Snapshot
11.20.2 Company Overview
11.20.3 Product Benchmarking
11.21 Research International
11.21.1 Company Snapshot
11.21.2 Company Overview
11.21.3 Product Benchmarking
11.22 Smith’s Detection
11.22.1 Company Snapshot
11.22.2 Company Overview
11.22.3 Product Benchmarking
11.22.4 Strategic Outlook
11.23 Synexis Systems
11.23.1 Company Snapshot
11.23.2 Company Overview
11.23.3 Product Benchmarking
11.23.4 Strategic Outlook

12 Conclusion and Recommendations
12.1 Concluding Remarks from Visiongain
12.2 Recommendations for Market Players

List of Tables
Table 1 Biodefence Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 3 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 4 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 5 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 6 Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 7 Biodefence Devices Market by Vaccines, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 8 Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 9 Biodefence Market Forecast by Product, 2023-2033 (US$ million)
Table 10 Anthrax Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 11 Small Pox Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 12 Botulism Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 13 Others Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 14 Assays and reagents Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 15 Detectors Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 16 Identifiers Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 17 Samplers Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 18 Biodefence Market Forecast by Region, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 19 North America Biodefence Market Forecast by Country
Table 20 North America Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 21 North America Biodefence Devices Market by Vaccines, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 22 North America Biodefence Devices Market by Biothreat detection devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 23 U.S. Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 24 Canada Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 25 Europe Biodefence Market Forecast by Country, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 26 Europe Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 27 Europe Biodefence Devices Market by Vaccines, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 28 Europe Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 29 Germany Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 30 France Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 31 UK Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 32 Italy Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 33 Spain Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 34 Russia Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 35 Rest of Europe Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 36 Asia Pacific Biodefence Market Forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 37 Asia Pacific Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 38 Asia Pacific Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 39 Asia Pacific Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR(%))
Table 40 Japan Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 41 China Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 42 India Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 43 Australia Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 44 South Korea Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 45 Rest of Asia Pacific Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 46 Latin America Biodefence forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 47 Latin America Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 48 Latin America Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 49 Latin America Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 50 Brazil Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 51 Mexico Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 52 Rest of Latin America Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 53 MEA Biodefence forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 54 MEA Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 55 MEA Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 56 MEA Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 57 GCC Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 58 South Africa Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 59 Rest of MEA Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 60 Alexeter Technologies, LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 61 Alexeter Technologies, LLC: Product Benchmarking
Table 62 Altimmune: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Altimmune: Product Benchmarking
Table 64 ANP Technology: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 65 ANP Technology: Product Benchmarking
Table 66 Bavarian Nordic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 67 Bavarian Nordic: Product Benchmarking
Table 68 Bavarian Nordic: Strategic Outlook
Table 69 Biofire Defense (bioMerieux SA): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 70 Biofire Defense (bioMerieux SA): Product Benchmarking
Table 71 Biofire Defense (bioMerieux SA.: Strategic Outlook
Table 72 Biosearch Technologies : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 73 Biosearch Technologies: Product Benchmarking
Table 74 Bruker: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 Bruker: Product Benchmarking
Table 76 Electronic Sensor Technology Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Electronic Sensor Technology Inc .: Product Benchmarking
Table 78 Elusys Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Elusys Therapeutics .: Product Benchmarking
Table 80 Elusys Therapeutics : Strategic Outlook
Table 81 Emergent BioSolutions Inc.: (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Emergent BioSolutions Inc.: Product Benchmarking
Table 83 Emergent BioSolutions Inc.: Strategic Outlook
Table 84 Ichor Medical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Ichor Medical: Product Benchmarking
Table 86 NanoLogix: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 NanoLogix: Product Benchmarking
Table 88 New Horizons Diagnostic Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 New Horizons Diagnostic Corporation: Product Benchmarking
Table 90 New Horizons Diagnostic Corporation: Strategic Outlook
Table 91 PositiveID Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 PositiveID Corporation .: Product Benchmarking
Table 93 SIGA Technologies, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 SIGA Technologies, Inc.: Product Benchmarking
Table 95 SIGA Technologies, Inc: Strategic Outlook
Table 96 Alnylam Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Alnylam Pharmaceuticals: Product Benchmarking
Table 98 Alnylam Pharmaceuticals: Strategic Outlook
Table 99 BBI Detection: Key Details, (CEO, HQ, Founded, No. of Employees, Business Segment)
Table 100 BBI Detection: Product Benchmarking
Table 101 Statera Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Statera Biopharma: Product Benchmarking
Table 103 Dynport Vaccine Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Dynport Vaccine Company: Product Benchmarking
Table 105 Research International: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Research International: Product Benchmarking
Table 107 Smith’s Detection: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Smith’s Detection : Product Benchmarking
Table 109 Smith’s Detection: Strategic Outlook
Table 110 Synexis Systems: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Synexis Systems: Product Benchmarking
Table 112 Synexis Systems: Strategic Outlook

List of Figures
Figure 1 Biodefence Market Segmentation
Figure 2 Biodefence Market by Product: Market Attractiveness Index
Figure 3 Biodefence Market by Vaccines: Market Attractiveness Index
Figure 4 Biodefence Market by Product: Market Attractiveness Index
Figure 5 Biodefence Market Attractiveness Index by Region
Figure 6 Biodefence Market: Market Dynamics
Figure 7 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 8 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 9 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 10 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 11 Biodefence Market: Porter’s Five Forces Analysis
Figure 12 Biodefence Market: PEST Analysis
Figure 13 Biodefence Market by Product: Market Attractiveness Index
Figure 14 Biodefence Market by Vaccines: Market Attractiveness Index
Figure 15 Biodefence Market by Product: Market Attractiveness Index
Figure 16 Biodefence Market Share Forecast by Product, 2023-2033 (%)
Figure 17 Anthrax Market Forecast by Region, 2023-2033 (US$ million)
Figure 18 Anthrax Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Small Pox Market Forecast by Region, 2023-2033 (US$ million)
Figure 20 Small Pox Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Botulism Market Forecast by Region, 2023-2033 (US$ million)
Figure 22 Botulism Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 24 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Assays and reagents Market Forecast by Region, 2023-2033 (US$ million)
Figure 26 Assays and reagents Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Detectors Market Forecast by Region, 2023-2033 (US$ million)
Figure 28 Detectors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Identifiers Market Forecast by Region, 2023-2033 (US$ million)
Figure 30 Identifiers Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Samplers Market Forecast by Region, 2023-2033 (US$ million)
Figure 32 Samplers Market Share Forecast by Region, 2023 & 2033 (%)
Figure 33 Biodefence Market by Region: Market Attractiveness Index
Figure 34 Biodefence Market by Region, 2023-2033 (US$ Mn)
Figure 35 Biodefence Market Share Forecast by Region 2023, 2033(%)
Figure 36 North America Biodefence Market Attractiveness Index
Figure 37 North America Biodefence Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 38 North America Biodefence Market Forecast by Country, 2023-2033 (US$ million)
Figure 39 North America Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
Figure 40 North America Biodefence Market Forecast by Product, 2023-2033 (US$ million)
Figure 41 North America Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
Figure 42 U.S. Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 43 Canada Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 44 Europe Biodefence Market Attractiveness Index
Figure 45 Europe Biodefence Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 46 Europe Biodefence Market Forecast by Country, 2023-2033 (US$ million)
Figure 47 Europe Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
Figure 48 Europe Biodefence Market Forecast by Product, 2023-2033 (US$ million)
Figure 49 Europe Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
Figure 50 Germany Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 51 France Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 52 UK Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 53 Italy Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 54 Spain Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 55 Russia Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 56 Rest of Europe Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 57 Asia Pacific Biodefence Market Attractiveness Index
Figure 58 Asia Pacific Biodefence Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 59 Asia Pacific Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 60 Asia Pacific Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
Figure 61 Asia Pacific Biodefence Market Forecast by Product, 2023-2033 (US$ million, AGR %)
Figure 62 Asia Pacific Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
Figure 63 Japan Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 64 China Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 65 India Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 66 Australia Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 67 South Korea Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 68 Rest of Asia Pacific Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 69 Latin America Biodefence Market Attractiveness Index
Figure 70 Latin America Biodefence Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 71 Latin America Biodefence Market Forecast by Country, 2023-2033 (US$ million)
Figure 72 Latin America Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
Figure 73 Latin America Biodefence Market Forecast by Product, 2023-2033 (US$ million)
Figure 74 Latin America Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
Figure 75 Brazil Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 76 Mexico Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 77 Rest of Latin America Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 78 MEA Biodefence Market Attractiveness Index
Figure 79 MEA Biodefence Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 80 MEA Biodefence Market Forecast by Country, 2023-2033 (US$ million)
Figure 81 MEA Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
Figure 82 MEA Biodefence Market Forecast by Product, 2023-2033 (US$ million)
Figure 83 MEA Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
Figure 84 GCC Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 85 South Africa Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 86 Rest of MEA Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 87 Altimmune: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 88 Altimmune: R&D, 2017-2021 (US$ million, AGR%)
Figure 89 Bavarian Nordic: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 90 Bavarian Nordic: R&D, 2017-2021 (US$ million, AGR%)
Figure 91 Bavarian Nordic: Regional Market Shares, 2021
Figure 92 Biofire Defense (bioMerieux SA): Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 93 Biofire Defense (bioMerieux SA): R&D, 2017-2021 (US$ million, AGR%)
Figure 94 Biofire Defense (bioMerieux SA): Regional Market Shares, 2021
Figure 95 Biosearch Technologies: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 96 Biosearch Technologies.: Regional Market Shares, 2021
Figure 97 Bruker: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 98 Bruker: R&D, 2017-2021 (US$ million, AGR%)
Figure 99 Bruker: Regional Market Shares, 2021
Figure 100 Emergent BioSolutions Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 101 Emergent BioSolutions Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 102 SIGA Technologies, Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 103 SIGA Technologies, Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 104 Alnylam Pharmaceuticals: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 105 Alnylam Pharmaceuticals: R&D, 2017-2021 (US$ million, AGR%)
Figure 106 Statera Biopharma: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 107 Statera Biopharma : R&D, 2017-2021 (US$ million, AGR%)